183 related articles for article (PubMed ID: 8389086)
1. A new mechanism of oncogenic activation: E26 retroviral v-ets oncogene has inverted the C-terminal end of the transcription factor c-ets-1.
Leprince D; Crepieux P; Laudet V; Flourens A; Stehelin D
Virology; 1993 Jun; 194(2):855-7. PubMed ID: 8389086
[TBL] [Abstract][Full Text] [Related]
2. Back-mutation of the V-Ets to the C-Ets carboxy-terminal amino acids in the P135gag-myb-ets results in chicken neuroretina cells transformation and loss of basic fibroblast growth factor responsiveness.
Garrido C; Leprince D; Plaza S; Aumercier M; Stéhelin D; Saule S
Oncogene; 1996 Apr; 12(7):1449-56. PubMed ID: 8622861
[TBL] [Abstract][Full Text] [Related]
3. c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.
Leprince D; Crepieux P; Stehelin D
Oncogene; 1992 Jan; 7(1):9-17. PubMed ID: 1741168
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
5. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
6. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
Reddy ES; Rao VN
Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
[TBL] [Abstract][Full Text] [Related]
7. The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.
Domenget C; Leprince D; Pain B; Peyrol S; Li RP; Stehelin D; Samarut J; Jurdic P
Oncogene; 1992 Nov; 7(11):2231-41. PubMed ID: 1331935
[TBL] [Abstract][Full Text] [Related]
8. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene.
Reddy ES; Rao VN
Cancer Res; 1990 Aug; 50(16):5013-6. PubMed ID: 2165853
[TBL] [Abstract][Full Text] [Related]
9. Phylogeny of the p68c-ets-1 amino-terminal transactivating domain reveals some highly conserved structural features.
Albagli O; Flourens A; Crepieux P; Begue A; Stehelin D; Leprince D
Oncogene; 1992 Jul; 7(7):1435-9. PubMed ID: 1620554
[TBL] [Abstract][Full Text] [Related]
10. The chicken cellular progenitor of the v-ets oncogene, p68c-ets-1, is a nuclear DNA-binding protein not expressed in lymphoid cells of the spleen.
Leprince D; Gesquiere JC; Stehelin D
Oncogene Res; 1990; 5(4):255-65. PubMed ID: 2204018
[TBL] [Abstract][Full Text] [Related]
11. Ets oncogene family.
Dhulipal PD
Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
[TBL] [Abstract][Full Text] [Related]
12. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
[TBL] [Abstract][Full Text] [Related]
13. p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo.
Quéva C; Leprince D; Stéhelin D; Vandenbunder B
Oncogene; 1993 Sep; 8(9):2511-20. PubMed ID: 8361762
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic conversion alters the transcriptional properties of ets.
Wasylyk C; Wasylyk B
Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
[TBL] [Abstract][Full Text] [Related]
15. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
Burk O; Worpenberg S; Haenig B; Klempnauer KH
EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
Hahn SL; Wasylyk B
Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
[TBL] [Abstract][Full Text] [Related]
17. A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.
Li RP; Duterque-Coquillaud M; Lagrou C; Debuire B; Graf T; Stehelin D; Leprince D
Oncogene Res; 1989; 5(2):137-41. PubMed ID: 2608278
[TBL] [Abstract][Full Text] [Related]
18. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of the transcription factor Elk-1.
Janknecht R; Zinck R; Ernst WH; Nordheim A
Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
